Rawls, S M <br/><br/>
Presynaptic kappa-opioid and muscarinic receptors inhibit the calcium-dependent component of evoked glutamate release from striatal synaptosomes.  [electronic resource] 

 -  Journal of neurochemistry  Sep 1999 
 - 1058-65 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3042 
<br/><br/><label>Standard No.: </label>10.1046/j.1471-4159.1999.0731058.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>4-Aminopyridine--pharmacology<br/>Animals<br/>Calcium--physiology<br/>Chelating Agents--pharmacology<br/>Dicarboxylic Acids--pharmacology<br/>Egtazic Acid--pharmacology<br/>Enkephalin, D-Penicillamine (2,5)-<br/>Enkephalins--pharmacology<br/>Glutamic Acid--metabolism<br/>In Vitro Techniques<br/>Male<br/>Muscarinic Agonists--pharmacology<br/>Muscarinic Antagonists--pharmacology<br/>Naltrexone--analogs & derivatives<br/>Narcotic Antagonists--pharmacology<br/>Neostriatum--drug effects<br/>Nerve Endings--drug effects<br/>Neurotransmitter Uptake Inhibitors--pharmacology<br/>Potassium Channel Blockers<br/>Potassium Channels--metabolism<br/>Pyrrolidines--pharmacology<br/>Rats<br/>Rats, Wistar<br/>Receptors, Muscarinic--drug effects<br/>Receptors, Opioid, kappa--drug effects<br/>Receptors, Presynaptic--drug effects<br/>Synaptosomes--drug effects